-
Clinical Outcome of Acute Bacterial Prostatitis; A Multicenter Study
-
Seong Ju Lee, Jin Mo Koo, Bong Suk Shim, Yong Hyun Cho, Chang Hee Han, Seung Ki Min, Sung Joo Lee, Hwan Cheol Son, Jun Mo Kim, Jong Bo Choi, Tae Hyoung Kim, Sang Kuk Yang, Kil Ho Lee, Yong Kil Na, Sung Ho Lee, Hee Jong Jung, Seung Il Jung, Chul Sung Kim, Jae Min Chung, Young Jin Seo, Won Yeol Cho, Kweon Sik Min, Sang Don Lee
-
Korean J Urogenit Tract Infect Inflamm 2011;6(2):165-170. Published online October 31, 2011
-
-
-
 Abstract
 PDF
- "Purpose: Proper guidelines concerning antibiotic administration for acute bacterial prostatitis (ABP) are unclear. We retrospectively analyzed treatment status and clinical outcomes to establish a proper treatment guideline. Materials and Methods: The clinical records of 669 patients from 21 hospitals diagnosed with ABP were reviewed. Prior manipulation, antibiotics administration, mean length of treatment, complication and procedure were analyzed. Results: The mean age of 538 patients (80.4%) without manipulation (group 1) and 131 patients (19.6%) with manipulation (group 2) was 58.3 years (range 19-88 years). Transrectal prostate biopsy was the most common cause of acute bacterial prostatitis (n=66; 50.4%). Of the clinical symptoms in the non-manipulation and manipulation groups, fever was most common (88.2% and 86.3%, respectively). Acute urinary retention (14.3% and 28.1%, respectively) was significantly increased in the manipulation group (p<0.05). Escherichia coli was the most frequently isolated bacterium from urine (72.0% and 66.7% of cases, respectively). Mean length of treatment was 6.5days and 7.9days, respectively; the difference was significant (p<0.05). Combination antibiotic therapy with third generation cephalosporin+aminoglycoside was used in 49.3% and 55.5% of cases, respectively. For single antibiotic therapy, second generation quinolones were used the most (35.5% and 34.3%, respectively). Sequale occurred in 29 group 1 patients (5.4%) and 20 group 2 patients (15.3%); the difference was significant (p<0.05). Conclusions: Prior manipulation was associated with 20% of ABP patients. Regardless of manipulation, clinical outcome was similar after treating with appropriate antibiotics."
-
Update of Non-gonococcal Urethritis
-
Ki Ho Kim, Young Jin Seo
-
Korean J Urogenit Tract Infect Inflamm 2011;6(1):25-31. Published online April 30, 2011
-
-
-
Abstract
PDF
- Urethritis in males not secondary to gonorrhea is classified as non-gonococcalurethritis (NGU). NGU is a common chlamydia-associated syndrome in men. However, Mycoplasma genitalium and Trichomonas vaginalis have been suggested as pathogens that cause NGU. In 20-30% of NGU cases, possible pathogens remain unidentified. Symptoms, if present, include mucopurulent or purulent discharge, dysuria, andurethral pruritis. Culture, nucleic acid hybridization tests, and nucleic acid amplification test are available for the detection of N. gonorrhoeae and C. trachomatis. Treatment should be initiated as soon as possible after diagnosis. Azithromycin and doxycycline are highly effective for chlamydial urethritis. However, infections with M. genitalium respond better to azithromycin.
|
KAUTI
